Cargando…

The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy

The tumor mutational burden (TMB) is increasingly recognized as an emerging biomarker that predicts improved outcomes or response to immune checkpoint inhibitors in cancer. A multitude of technical and biological factors make it difficult to compare TMB values across platforms, histologies, and trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golkaram, Mahdi, Zhao, Chen, Kruglyak, Kristina, Zhang, Shile, Bilke, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676656/ https://www.ncbi.nlm.nih.gov/pubmed/33166276 http://dx.doi.org/10.1371/journal.pcbi.1008332

Ejemplares similares

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Analysis of Threshold Change of Tumor Mutation Burden in Gastric Cancer
por: He, Xinwei, et al.
Publicado: (2021)

Evidence for a Functional Link between Chromosomal Breakpoints and Aberrant DNA Methylation in Cancer
por: Bilke, Sven, et al.
Publicado: (2014)

The Interplay between T Cells and Cancer: The Basis of Immunotherapy
por: Chen, Christina, et al.
Publicado: (2023)

A compartment size-dependent selective threshold limits mutation accumulation in hierarchical tissues
por: Grajzel, Dániel, et al.
Publicado: (2020)

Tumor mutational burden as a predictor of immunotherapy response in breast cancer
por: O’Meara, Tess A., et al.
Publicado: (2021)

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel
por: Zhuang, Wu, et al.
Publicado: (2018)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

The interplay between eosinophils and T cells in breast cancer immunotherapy
por: Zerdes, Ioannis, et al.
Publicado: (2023)

Analysis of Threshold Changes of Tumor Mutation Burden of Gastric Cancer and Its Relationship with Patients' Prognosis
por: Zhang, Nan, et al.
Publicado: (2021)

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
por: Wang, Zhijie, et al.
Publicado: (2019)

Interplay between the DNA Damage Response and Immunotherapy Response in Cancer
por: Lee, Elizabeth Chun Yong, et al.
Publicado: (2022)

Clinicopathological Features, Tumor Mutational Burden, and Tumour-Infiltrating Lymphocyte Interplay in ERBB2-Mutated Breast Cancer: In Silico Analysis
por: Uchida, Shiro, et al.
Publicado: (2021)

Tumor mutational burden and immune signatures interplay in renal cell carcinoma
por: Yakirevich, Evgeny, et al.
Publicado: (2020)

High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes
por: Kalender Atak, Zeynep, et al.
Publicado: (2012)

Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy
por: Aggarwal, Charu, et al.
Publicado: (2023)

The Bilateral Interplay between Cancer Immunotherapies and Neutrophils’ Phenotypes and Sub-Populations
por: Kaisar-Iluz, Naomi, et al.
Publicado: (2022)

Panels and models for accurate prediction of tumor mutation burden in tumor samples
por: Martínez-Pérez, Elizabeth, et al.
Publicado: (2021)

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation
por: Li, Yawei, et al.
Publicado: (2021)

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
por: Gromeier, Matthias, et al.
Publicado: (2021)

Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review
por: Zhu, Peng-Fei, et al.
Publicado: (2021)

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
por: Sinha, Neelam, et al.
Publicado: (2022)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
por: Koustas, Evangelos, et al.
Publicado: (2019)

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
por: Lauriola, Angela, et al.
Publicado: (2023)

Assessment of tumor mutation burden calculation from gene panel sequencing data
por: Xu, Zhenwu, et al.
Publicado: (2019)

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
por: Wood, Mary A., et al.
Publicado: (2020)

Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy
por: Heumos, Simon, et al.
Publicado: (2022)

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
por: Yang, Yue, et al.
Publicado: (2020)

Probabilistic estimation of microarray data reliability and underlying gene expression
por: Bilke, Sven, et al.
Publicado: (2003)

Replicon: a software to accurately predict DNA replication timing in metazoan cells
por: Gindin, Yevgeniy, et al.
Publicado: (2014)

An interplay of resource availability, population size and mutation rate potentiates the evolution of metabolic signaling
por: Kumawat, Bhaskar, et al.
Publicado: (2021)

Editorial: Interplay between oncomicrobes, the microbiota and the immune system: impact on responses to cancer immunotherapy
por: Dorta-Estremera, Stephanie M., et al.
Publicado: (2023)

When genetic burden reaches threshold
por: Walsh, Roddy, et al.
Publicado: (2020)

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
por: Pham, Timothy V., et al.
Publicado: (2020)

Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
por: Fancello, Laura, et al.
Publicado: (2019)

Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
por: Lawlor, Rita T., et al.
Publicado: (2021)

Immunotherapy and tumor mutational burden in cancer patients with liver metastases: A meta and real word cohort analysis
por: Wu, Rui-Yan, et al.
Publicado: (2023)

Considerations for Patient Panel Size
por: Harrington, Caroline
Publicado: (2022)

Macroevolutionary patterns of bumblebee body size: detecting the interplay between natural and sexual selection
por: del Castillo, Raúl Cueva, et al.
Publicado: (2012)

Chromosome size affects sequence divergence between species through the interplay of recombination and selection
por: Tigano, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3uh5lo4q34dorks0kgfkmogdio